This manuscript reviews mass spectrometry methods and limitations for analisys of biological fluids in the search for biomarkers that can aid medical diagnosis. Currently, mass spectrometry has the ability to discriminate differentially expressed molecular patterns among cancer patients and control subjects. Results in the literature point mass spectrometry as having a major role in the future of medical diagnosis.
Mass spectrometry; Proteomics; Biomarker; Cancer
